AstraZeneca's Kid Asthma Drug Patent Deemed Obvious
A New Jersey federal judge on Friday opened the door for Sandoz Inc., Apotex Inc. and other competitors of AstraZeneca PLC to launch generic versions of its pediatric asthma medication, finding...To view the full article, register now.
Already a subscriber? Click here to view full article